Compare UMBF & ICUI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | UMBF | ICUI |
|---|---|---|
| Founded | 1913 | 1984 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Major Banks | Medical/Dental Instruments |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 9.2B | 3.6B |
| IPO Year | N/A | 1992 |
| Metric | UMBF | ICUI |
|---|---|---|
| Price | $126.26 | $155.25 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 11 | 5 |
| Target Price | $135.64 | ★ $179.50 |
| AVG Volume (30 Days) | ★ 433.3K | 224.1K |
| Earning Date | 01-27-2026 | 02-26-2026 |
| Dividend Yield | ★ 1.43% | N/A |
| EPS Growth | ★ 10.98 | N/A |
| EPS | ★ 8.89 | N/A |
| Revenue | $2,217,071,000.00 | ★ $2,320,363,000.00 |
| Revenue This Year | $69.52 | N/A |
| Revenue Next Year | $7.83 | N/A |
| P/E Ratio | $13.55 | ★ N/A |
| Revenue Growth | ★ 45.52 | N/A |
| 52 Week Low | $82.00 | $107.00 |
| 52 Week High | $126.14 | $175.51 |
| Indicator | UMBF | ICUI |
|---|---|---|
| Relative Strength Index (RSI) | 64.50 | 61.35 |
| Support Level | $120.01 | $146.33 |
| Resistance Level | $124.11 | $157.91 |
| Average True Range (ATR) | 3.26 | 5.30 |
| MACD | 0.24 | 0.44 |
| Stochastic Oscillator | 93.82 | 86.45 |
UMB Financial Corp, or UMBF, is a financial services holding company offering a suite of banking services and asset servicing to its customers in the United States and around the world. Its client base includes commercial, institutional, and personal customers. Along with its subsidiaries, the company operates in the following business segments: Commercial Banking, Institutional Banking, and Personal Banking. A majority of its revenue is generated from the Commercial Banking segment, which serves the commercial banking and treasury management needs of small to middle-market businesses through various products and services such as commercial loans, commercial real estate financing, commercial credit cards, letters of credit, loan syndication services, consultative services, and others.
ICU Medical is a California-based pure-play infusion therapy company that provides consumables, systems, and services for virtually every component of the IV continuum of care. ICU has become one of the largest players in its industry following its acquisition of Hospira Infusion Systems from Pfizer in 2017 and Smiths Medical from Smiths Group in 2022. It holds top-tier positions across its three reporting segments: consumables (50% of consolidated revenue), infusion systems (30%), and vital care (20%). The combined entity remains primarily US-focused, generating over 60% of its sales domestically.